ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AscellaHealth Expands Leadership Team to Accelerate Growth, Strengthen Operations and Advance Patient-Centric Solutions

NotifiedPR_Image_MAR-178-021925.1

BERWYN, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA, Senior Vice President, Payer Business Unit and Carl T. Bertram, PharmD, MS, MBA, Senior Vice President, Pharma Business Unit. These strategic roles will be instrumental in driving performance across the organization, elevating client and partner experiences and advancing AscellaHealth’s mission to improve access to innovative therapies and enhance clinical outcomes for individuals with rare and complex conditions.

Welcoming these accomplished professionals, Bill Oldham, chairman and president, AscellaHealth, says, “With their proven success in delivering results across diverse healthcare settings and driving growth in various business sectors, Clayton and Carl will be key contributors to our ongoing operational and financial success. Their deep industry knowledge and experience are directly aligned with our business model and patient-focused care approach. As critical members of our executive team, their leadership will further strengthen our position as a trusted partner within the specialty healthcare ecosystem.”

Clayton Edwards, RPh, MBA – Senior Vice President, Payer Business Unit

Edwards is an industry veteran with extensive experience leading various sectors within the healthcare industry, consistently fostering innovation and growth. Throughout his career, he has held influential roles at renowned organizations, such as CarelonRx Pharmacy, AllianceRx Walgreens Prime, CareSource Management Group, OptumRx and UnitedHealthcare.

With a strong background in mergers and acquisitions, Edwards has played a key role in M&A activity across 12 companies, collectively valued at over $19 billion. He has been deeply involved in business development and revenue expansion, identifying acquisition opportunities, conducting due diligence and driving successful post-transaction integration.

Edwards has been instrumental in developing and executing sales, marketing and clinical strategies that led to $8 billion in new sales and established robust customer relationships, achieving an impressive 98.5% retention rate. He has demonstrated global leadership by managing a team of over 6,000 professionals across 27 domestic and four international locations, overseeing key areas such as proposals, contract management, new account installations and leading a dedicated client success team for health services.

“With 34 years of experience across various healthcare organizations, I have built a solid foundation to develop and implement AscellaHealth’s strategies for payers in both public and private sectors,” says Edwards. “I am excited to drive collaborations between payers, drug manufacturers and providers, while advancing solutions that enhance member engagement and improve the overall treatment experience.”

Carl T. Bertram, PharmD, MS, MBA – Senior Vice President, Pharma Business Unit

With over 30 years of experience, Bertram is a senior healthcare executive with extensive expertise in delivering impactful value propositions across specialty pharmacy, managed care, retail and group purchasing organizations. A proven leader in transformation, he has successfully developed innovative health services models, operational strategies, clinical systems and product development initiatives. Bertram has held senior management roles at prestigious organizations, including Walgreens, Walmart, CVS Health, Cigna Health Plan, EnvisionRx PBM, Managed Healthcare Associates and Catamaran (now OptumRx).

Bertram has spearheaded strategic partnerships and initiatives with pharmaceutical manufacturers, payers, providers, wholesalers and technology vendors. He has successfully managed multimillion-dollar budgets, led large-scale operational teams and developed high-impact clinical models, demonstrating exceptional leadership in driving revenue growth and enhancing operational efficiencies.

Recognized as an industry expert and thought leader in pharmacy and innovative business models, Bertram has developed and implemented comprehensive programs across commercialization, operations, clinical and digital services, as well as analytics and insights. He is credited with executing strategies that produced measurable results, including managing Medicaid and Medicare Part D programs, overseeing quality assurance, contributing to formulary decision-making and leading specialty pharmacy operations. Additionally, Bertram holds several patents for clinical technology systems, underscoring his commitment to advancing healthcare solutions.

Bertram says, “As AscellaHealth continues its impressive growth, I look forward to leveraging my extensive experience in building, leading and developing teams. Over the years, I’ve witnessed a shifting global healthcare landscape and see numerous opportunities to assist our clients in launching new therapies or expanding market share for existing products. I am excited to strengthen AscellaHealth’s strategic position, helping specialty pharmaceutical manufacturers accelerate the discovery and commercialization of life-changing therapies that improve the lives of patients with rare and complex, chronic conditions.”

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. For more information on our services and solutions, visit www.AscellaHealth.com.

An image accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/788c8982-bbf5-46c4-985f-79af0b7ed63c

This press release was published by a CLEAR® Verified individual.


Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.